Robert C Knipper, CRNA - Medicare Certified Registered Nurse Anesthetist (crna) in Bullhead City, AZ

Robert C Knipper, CRNA is a medicare enrolled "Nurse Anesthetist, Certified Registered" in Bullhead City, Arizona. He graduated from nursing school in 2005 and has 19 years of diverse experience with area of expertise as Certified Registered Nurse Anesthetist (crna). He is a member of the group practice G And G Anesthesia Llc, Temecula Ca Endoscopy Asc Lp, United Medical Doctors and his current practice location is 2735 Silver Creek Rd, Bullhead City, Arizona. You can reach out to his office (for appointments etc.) via phone at (928) 763-2273.

Robert C Knipper is licensed to practice in California (license number 3474) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1972600427.

Contact Information

Robert C Knipper, CRNA
2735 Silver Creek Rd,
Bullhead City, AZ 86442-7924
(928) 763-2273
Not Available



Provider's Profile

Full NameRobert C Knipper
GenderMale
SpecialityCertified Registered Nurse Anesthetist (crna)
Experience19 Years
Location2735 Silver Creek Rd, Bullhead City, Arizona
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Robert C Knipper graduated from nursing school in 2005
  NPI Data:
  • NPI Number: 1972600427
  • Provider Enumeration Date: 09/19/2006
  • Last Update Date: 10/04/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 4284936162
  • Enrollment ID: I20160108001999

Medical Identifiers

Medical identifiers for Robert C Knipper such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1972600427NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
367500000XNurse Anesthetist, Certified Registered 0024166850 (Virginia)Secondary
367500000XNurse Anesthetist, Certified Registered 3474 (California)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
G And G Anesthesia Llc498191260769
Temecula Ca Endoscopy Asc Lp498164567818
United Medical Doctors2961305651105

News Archive

Sugared-sweetened beverages eliminated from Nationwide Children's Hospital campus

According to the American Academy of Pediatrics, sweetened drinks are the primary source of added sugar in the daily diet of children. Each 12-ounce serving of a carbonated, sweetened soft drink contains the equivalent of 10 teaspoons of sugar and 150 calories. A child who consumes one can of regular soda needs to walk 45 minutes just to burn it off.

Obagi Medical Products prices secondary offering

Obagi Medical Products, Inc., a leader in topical aesthetic and therapeutic skin health systems, today announced the pricing of the secondary public offering of 2,690,244 shares of its common stock by the Stonington Capital Appreciation 1994 Fund, L.P. and the Zein and Samar Obagi Family Trust, at a public offering price of $10.25 per share.

Researchers reveal how genome-editing tool works as 'guided missile' to correct errors in genetic code

Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first high definition picture of the Cas9 complex - a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells. Their findings, which are reported this week in Cell, are expected to help researchers refine and further engineer the tool to accelerate genomic research and bring the technology closer to use in the treatment of human genetic disease.

IMRIS obtains regulatory approval to market surgical imaging systems in South Korea

IMRIS Inc. ("IMRIS" or the "Company") today announced that it has gained regulatory approval from the Korea Food & Drug Administration permitting the Company to immediately begin marketing its 1.5 Tesla and 3.0 Tesla IMRISneuro systems in South Korea.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Robert C Knipper allows following entities to bill medicare on his behalf.
Entity NameUnited Medical Doctors
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1770559981
PECOS PAC ID: 2961305651
Enrollment ID: O20040129001069

News Archive

Sugared-sweetened beverages eliminated from Nationwide Children's Hospital campus

According to the American Academy of Pediatrics, sweetened drinks are the primary source of added sugar in the daily diet of children. Each 12-ounce serving of a carbonated, sweetened soft drink contains the equivalent of 10 teaspoons of sugar and 150 calories. A child who consumes one can of regular soda needs to walk 45 minutes just to burn it off.

Obagi Medical Products prices secondary offering

Obagi Medical Products, Inc., a leader in topical aesthetic and therapeutic skin health systems, today announced the pricing of the secondary public offering of 2,690,244 shares of its common stock by the Stonington Capital Appreciation 1994 Fund, L.P. and the Zein and Samar Obagi Family Trust, at a public offering price of $10.25 per share.

Researchers reveal how genome-editing tool works as 'guided missile' to correct errors in genetic code

Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first high definition picture of the Cas9 complex - a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells. Their findings, which are reported this week in Cell, are expected to help researchers refine and further engineer the tool to accelerate genomic research and bring the technology closer to use in the treatment of human genetic disease.

IMRIS obtains regulatory approval to market surgical imaging systems in South Korea

IMRIS Inc. ("IMRIS" or the "Company") today announced that it has gained regulatory approval from the Korea Food & Drug Administration permitting the Company to immediately begin marketing its 1.5 Tesla and 3.0 Tesla IMRISneuro systems in South Korea.

Read more Medical News

› Verified 7 days ago

Entity NameTemecula Ca Endoscopy Asc Lp
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1285863696
PECOS PAC ID: 4981645678
Enrollment ID: O20090730000041

News Archive

Sugared-sweetened beverages eliminated from Nationwide Children's Hospital campus

According to the American Academy of Pediatrics, sweetened drinks are the primary source of added sugar in the daily diet of children. Each 12-ounce serving of a carbonated, sweetened soft drink contains the equivalent of 10 teaspoons of sugar and 150 calories. A child who consumes one can of regular soda needs to walk 45 minutes just to burn it off.

Obagi Medical Products prices secondary offering

Obagi Medical Products, Inc., a leader in topical aesthetic and therapeutic skin health systems, today announced the pricing of the secondary public offering of 2,690,244 shares of its common stock by the Stonington Capital Appreciation 1994 Fund, L.P. and the Zein and Samar Obagi Family Trust, at a public offering price of $10.25 per share.

Researchers reveal how genome-editing tool works as 'guided missile' to correct errors in genetic code

Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first high definition picture of the Cas9 complex - a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells. Their findings, which are reported this week in Cell, are expected to help researchers refine and further engineer the tool to accelerate genomic research and bring the technology closer to use in the treatment of human genetic disease.

IMRIS obtains regulatory approval to market surgical imaging systems in South Korea

IMRIS Inc. ("IMRIS" or the "Company") today announced that it has gained regulatory approval from the Korea Food & Drug Administration permitting the Company to immediately begin marketing its 1.5 Tesla and 3.0 Tesla IMRISneuro systems in South Korea.

Read more Medical News

› Verified 7 days ago

Entity NameAnesthesia Medical Group Of Imperial Valley Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1487087136
PECOS PAC ID: 9335379775
Enrollment ID: O20140303001946

News Archive

Sugared-sweetened beverages eliminated from Nationwide Children's Hospital campus

According to the American Academy of Pediatrics, sweetened drinks are the primary source of added sugar in the daily diet of children. Each 12-ounce serving of a carbonated, sweetened soft drink contains the equivalent of 10 teaspoons of sugar and 150 calories. A child who consumes one can of regular soda needs to walk 45 minutes just to burn it off.

Obagi Medical Products prices secondary offering

Obagi Medical Products, Inc., a leader in topical aesthetic and therapeutic skin health systems, today announced the pricing of the secondary public offering of 2,690,244 shares of its common stock by the Stonington Capital Appreciation 1994 Fund, L.P. and the Zein and Samar Obagi Family Trust, at a public offering price of $10.25 per share.

Researchers reveal how genome-editing tool works as 'guided missile' to correct errors in genetic code

Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first high definition picture of the Cas9 complex - a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells. Their findings, which are reported this week in Cell, are expected to help researchers refine and further engineer the tool to accelerate genomic research and bring the technology closer to use in the treatment of human genetic disease.

IMRIS obtains regulatory approval to market surgical imaging systems in South Korea

IMRIS Inc. ("IMRIS" or the "Company") today announced that it has gained regulatory approval from the Korea Food & Drug Administration permitting the Company to immediately begin marketing its 1.5 Tesla and 3.0 Tesla IMRISneuro systems in South Korea.

Read more Medical News

› Verified 7 days ago

Entity NameTemecula Ca United Surgery Center Lp
Entity TypePart B Supplier - Ambulatory Surgical Center
Entity IdentifiersNPI Number: 1275951196
PECOS PAC ID: 9436465853
Enrollment ID: O20150831003140

News Archive

Sugared-sweetened beverages eliminated from Nationwide Children's Hospital campus

According to the American Academy of Pediatrics, sweetened drinks are the primary source of added sugar in the daily diet of children. Each 12-ounce serving of a carbonated, sweetened soft drink contains the equivalent of 10 teaspoons of sugar and 150 calories. A child who consumes one can of regular soda needs to walk 45 minutes just to burn it off.

Obagi Medical Products prices secondary offering

Obagi Medical Products, Inc., a leader in topical aesthetic and therapeutic skin health systems, today announced the pricing of the secondary public offering of 2,690,244 shares of its common stock by the Stonington Capital Appreciation 1994 Fund, L.P. and the Zein and Samar Obagi Family Trust, at a public offering price of $10.25 per share.

Researchers reveal how genome-editing tool works as 'guided missile' to correct errors in genetic code

Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first high definition picture of the Cas9 complex - a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells. Their findings, which are reported this week in Cell, are expected to help researchers refine and further engineer the tool to accelerate genomic research and bring the technology closer to use in the treatment of human genetic disease.

IMRIS obtains regulatory approval to market surgical imaging systems in South Korea

IMRIS Inc. ("IMRIS" or the "Company") today announced that it has gained regulatory approval from the Korea Food & Drug Administration permitting the Company to immediately begin marketing its 1.5 Tesla and 3.0 Tesla IMRISneuro systems in South Korea.

Read more Medical News

› Verified 7 days ago

Entity NameG & G Anesthesia Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1487020111
PECOS PAC ID: 4981912607
Enrollment ID: O20200512001499

News Archive

Sugared-sweetened beverages eliminated from Nationwide Children's Hospital campus

According to the American Academy of Pediatrics, sweetened drinks are the primary source of added sugar in the daily diet of children. Each 12-ounce serving of a carbonated, sweetened soft drink contains the equivalent of 10 teaspoons of sugar and 150 calories. A child who consumes one can of regular soda needs to walk 45 minutes just to burn it off.

Obagi Medical Products prices secondary offering

Obagi Medical Products, Inc., a leader in topical aesthetic and therapeutic skin health systems, today announced the pricing of the secondary public offering of 2,690,244 shares of its common stock by the Stonington Capital Appreciation 1994 Fund, L.P. and the Zein and Samar Obagi Family Trust, at a public offering price of $10.25 per share.

Researchers reveal how genome-editing tool works as 'guided missile' to correct errors in genetic code

Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first high definition picture of the Cas9 complex - a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells. Their findings, which are reported this week in Cell, are expected to help researchers refine and further engineer the tool to accelerate genomic research and bring the technology closer to use in the treatment of human genetic disease.

IMRIS obtains regulatory approval to market surgical imaging systems in South Korea

IMRIS Inc. ("IMRIS" or the "Company") today announced that it has gained regulatory approval from the Korea Food & Drug Administration permitting the Company to immediately begin marketing its 1.5 Tesla and 3.0 Tesla IMRISneuro systems in South Korea.

Read more Medical News

› Verified 7 days ago

Entity NameLifelinc Anesthesia Vi Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1487221628
PECOS PAC ID: 0749688000
Enrollment ID: O20211018001772

News Archive

Sugared-sweetened beverages eliminated from Nationwide Children's Hospital campus

According to the American Academy of Pediatrics, sweetened drinks are the primary source of added sugar in the daily diet of children. Each 12-ounce serving of a carbonated, sweetened soft drink contains the equivalent of 10 teaspoons of sugar and 150 calories. A child who consumes one can of regular soda needs to walk 45 minutes just to burn it off.

Obagi Medical Products prices secondary offering

Obagi Medical Products, Inc., a leader in topical aesthetic and therapeutic skin health systems, today announced the pricing of the secondary public offering of 2,690,244 shares of its common stock by the Stonington Capital Appreciation 1994 Fund, L.P. and the Zein and Samar Obagi Family Trust, at a public offering price of $10.25 per share.

Researchers reveal how genome-editing tool works as 'guided missile' to correct errors in genetic code

Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first high definition picture of the Cas9 complex - a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells. Their findings, which are reported this week in Cell, are expected to help researchers refine and further engineer the tool to accelerate genomic research and bring the technology closer to use in the treatment of human genetic disease.

IMRIS obtains regulatory approval to market surgical imaging systems in South Korea

IMRIS Inc. ("IMRIS" or the "Company") today announced that it has gained regulatory approval from the Korea Food & Drug Administration permitting the Company to immediately begin marketing its 1.5 Tesla and 3.0 Tesla IMRISneuro systems in South Korea.

Read more Medical News

› Verified 7 days ago

Entity NameSound Physicians Anesthesiology Of California Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1699408229
PECOS PAC ID: 4385027770
Enrollment ID: O20220817003296

News Archive

Sugared-sweetened beverages eliminated from Nationwide Children's Hospital campus

According to the American Academy of Pediatrics, sweetened drinks are the primary source of added sugar in the daily diet of children. Each 12-ounce serving of a carbonated, sweetened soft drink contains the equivalent of 10 teaspoons of sugar and 150 calories. A child who consumes one can of regular soda needs to walk 45 minutes just to burn it off.

Obagi Medical Products prices secondary offering

Obagi Medical Products, Inc., a leader in topical aesthetic and therapeutic skin health systems, today announced the pricing of the secondary public offering of 2,690,244 shares of its common stock by the Stonington Capital Appreciation 1994 Fund, L.P. and the Zein and Samar Obagi Family Trust, at a public offering price of $10.25 per share.

Researchers reveal how genome-editing tool works as 'guided missile' to correct errors in genetic code

Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first high definition picture of the Cas9 complex - a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells. Their findings, which are reported this week in Cell, are expected to help researchers refine and further engineer the tool to accelerate genomic research and bring the technology closer to use in the treatment of human genetic disease.

IMRIS obtains regulatory approval to market surgical imaging systems in South Korea

IMRIS Inc. ("IMRIS" or the "Company") today announced that it has gained regulatory approval from the Korea Food & Drug Administration permitting the Company to immediately begin marketing its 1.5 Tesla and 3.0 Tesla IMRISneuro systems in South Korea.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Robert C Knipper is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Robert C Knipper, CRNA
1135 Calistoga Way,
San Marcos, CA 92078-1018

Ph: (760) 842-3334
Robert C Knipper, CRNA
2735 Silver Creek Rd,
Bullhead City, AZ 86442-7924

Ph: (928) 763-2273

News Archive

Sugared-sweetened beverages eliminated from Nationwide Children's Hospital campus

According to the American Academy of Pediatrics, sweetened drinks are the primary source of added sugar in the daily diet of children. Each 12-ounce serving of a carbonated, sweetened soft drink contains the equivalent of 10 teaspoons of sugar and 150 calories. A child who consumes one can of regular soda needs to walk 45 minutes just to burn it off.

Obagi Medical Products prices secondary offering

Obagi Medical Products, Inc., a leader in topical aesthetic and therapeutic skin health systems, today announced the pricing of the secondary public offering of 2,690,244 shares of its common stock by the Stonington Capital Appreciation 1994 Fund, L.P. and the Zein and Samar Obagi Family Trust, at a public offering price of $10.25 per share.

Researchers reveal how genome-editing tool works as 'guided missile' to correct errors in genetic code

Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first high definition picture of the Cas9 complex - a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells. Their findings, which are reported this week in Cell, are expected to help researchers refine and further engineer the tool to accelerate genomic research and bring the technology closer to use in the treatment of human genetic disease.

IMRIS obtains regulatory approval to market surgical imaging systems in South Korea

IMRIS Inc. ("IMRIS" or the "Company") today announced that it has gained regulatory approval from the Korea Food & Drug Administration permitting the Company to immediately begin marketing its 1.5 Tesla and 3.0 Tesla IMRISneuro systems in South Korea.

Read more News

› Verified 7 days ago


Nurse Anesthetist, Certified Registered Nurses in Bullhead City, AZ

Mr. Alexis Perez, CRNA
Nurse Anesthetist - CR
Medicare: Not Enrolled in Medicare
Practice Location: 2735 Silver Creek Rd, Bullhead City, AZ 86442
Phone: --    
Danielle Jordan,
Nurse Anesthetist - CR
Medicare: Not Enrolled in Medicare
Practice Location: 2735 Silver Creek Rd, Bullhead City, AZ 86442
Phone: 928-763-2273    
Christian Beesley,
Nurse Anesthetist - CR
Medicare: Not Enrolled in Medicare
Practice Location: 2735 Silver Creek Rd, Bullhead City, AZ 86442
Phone: 928-763-2273    
Joshua Douglas Harper, CRNA
Nurse Anesthetist - CR
Medicare: Medicare Enrolled
Practice Location: 2735 Silver Creek Rd, Bullhead City, AZ 86442
Phone: 503-936-7730    
Barry H Latimer, CRNA
Nurse Anesthetist - CR
Medicare: Not Enrolled in Medicare
Practice Location: 2735 Silver Creek Rd, Bullhead City, AZ 86442
Phone: 602-273-6770    Fax: 602-889-0489

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.